The DOI matches its Crossref record; 383 of the 388 references it cites were found in a registry or an index.
Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host
Open accessAbstract
Infection and inflammation induce the acute-phase response (APR), leading to multiple alterations in lipid and lipoprotein metabolism. Plasma triglyceride levels increase from increased VLDL secretion as a result of adipose tissue lipolysis, increased de novo hepatic fatty acid synthesis, and suppression of fatty acid oxidation. With more severe infection, VLDL clearance decreases secondary to decreased lipoprotein lipase and apolipoprotein E in VLDL. In rodents, hypercholesterolemia occurs attributable to increased hepatic cholesterol synthesis and decreased LDL clearance, conversion of cholesterol to bile acids, and secretion of cholesterol into the bile. Marked alterations in proteins important in HDL metabolism lead to decreased reverse cholesterol transport and increased cholesterol delivery to immune cells. Oxidation of LDL and VLDL increases, whereas HDL becomes a proinflammatory molecule. Lipoproteins become enriched in ceramide, glucosylceramide, and sphingomyelin, enhancing uptake by macrophages. Thus, many of the changes in lipoproteins are proatherogenic. The molecular mechanisms underlying the decrease in many of the proteins during the APR involve coordinated decreases in several nuclear hormone receptors, including peroxisome proliferator-activated receptor, liver X receptor, farnesoid X receptor, and retinoid X receptor. APR-induced alterations initially protect the host from the harmful effects of bacteria, viruses, and parasites. However, if prolonged, these changes in the structure and function of lipoproteins will contribute to atherogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Decreases in HDL and LDL cholesterol, as well as RCT, belong to the metabolic adaptations found in APR during inflammatory attack67.”
From Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses (2016) · cites this paper as [67]
In the citing paper
“Many acute conditions, including surgical trauma, myocardial infarction and inflammation, induce the systemic acute phase reaction (APR), with acute phase protein production in the liver as an integral part of the host defence response.”
From Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses (2016) · cites this paper as [67]
In the citing paper
“In addition to changes in protein synthesis, also lipid metabolism undergoes significant modifications in APR6667.”
From Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses (2016) · cites this paper as [67]
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 4,694
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,165
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
Research works printed but not linked: 1
- Meng, 2001, Cancer Res., 61, 2250
Cited by
Sorted by citations
Items 701–800 of 1,000
Thaveeratitham, P., Plengpanich, W., Naen-Udorn, W., Patumraj, S., & Khovidhunkit, W. (2007) · Journal of Endotoxin Research · doi:10.1177/0968051907078611 · Cited by 20
Self-citationHBV inhibits apoB production via the suppression of MTP expression
Wang, X., Zhu, C., Liu, X., & Gao, G. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-207 · Cited by 20
Zhang, K., Zhao, M. ‐., An, Q., Jia, Y., Fu, L., Xu, J., & Gu, Y. (2017) · Andrology · doi:10.1111/andr.12425 · Cited by 21
Desroches, S., Archer, W. R., Paradis, M., Dériaz, O., Couture, P., Bergeron, J., Bergeron, N., & Lamarche, B. (2006) · Journal of Nutrition · doi:10.1093/jn/136.4.1005 · Cited by 20
Guo, J., Mutailipu, K., Wen, X., Yin, J., You, H., Qu, S., Chen, H., & Bu, L. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-024-02411-7 · Cited by 20
Worede, A., Nigatie, M., Melak, T., & Asmelash, D. (2022) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s368832 · Cited by 19
Wang, W., Kou, J., Zhang, M., Wang, T., Li, W., Wang, Y., Xie, Q., & Wei, M. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-03585-z · Cited by 19
Human Plasma Lipid Modulation in Schistosomiasis Mansoni Depends on Apolipoprotein E Polymorphism
da Fonseca, C. S. M., Filho, A. A. P., dos Santos, B. S., da Silva, C. A., Domingues, A. L. C., Owen, J. S., & Lima, V. L. D. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101964 · Cited by 19
Khazen, W., Distel, E., Collinet, M., Chaves, V. E., Mbika, J., Chany, C., Achour, A., Benelli, C., & Forest, C. D. (2007) · Endocrinology · doi:10.1210/en.2006-1760 · Cited by 19
Clinical Significance of High-Density Lipoprotein Cholesterol in Left-Sided Infective Endocarditis
Kahvecı, G., Bayrak, F., Mutlu, B., Gürel, Y. E., Karaahmet, T., Tigen, K., & Başaran, Y. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.075 · Cited by 19
Cesari, M., Marzetti, E., Laudisio, A., Antonica, L., Pahor, M., Bernabei, R., & Zuccalà, G. (2009) · Age and Ageing · doi:10.1093/ageing/afp194 · Cited by 19
Correlation Between Apolipoprotein M and Inflammatory Factors in Obese Patients
Li, T., Yang, L., Zhao, S., & Zhang, S. (2018) · Medical Science Monitor · doi:10.12659/msm.907744 · Cited by 17
Gudbrandsen, O. A., Dankel, S. N., Skumsnes, L., Flølo, T. N., Folkestad, O. H., Nielsen, H. J., Våge, V., Mohn, A. C., Nedrebø, B. G., Sagen, J. V., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51347-x · Cited by 18
HDL Composition, Heart Failure, and Its Comorbidities
Diab, A., Ripoll, C. V., Guo, Z., & Javaheri, A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.846990 · Cited by 24
Altered Lipid Levels in Untreated Patients with Early Polymyositis
Wang, H., Cai, Y., Cai, L., Hu, Y., Chen, X., & Deng, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089827 · Cited by 19
Growth hormone and HIV infection: Contribution to disease manifestations and clinical implications
Falutz, J. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.11.001 · Cited by 19
The Scl1 of M41-type group A Streptococcus binds the high-density lipoprotein
Gao, Y., Liang, C., Zhao, R., Łukomski, S., & Han, R. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02013.x · Cited by 19
Status of vitamins A and E in schoolchildren in the centre west of Tunisia: a population-based study
Fares, S., Chahed, M. K., Feki, M., Beji, C., Traissac, P., Ati, J. E., & Kaabachi, N. (2010) · Public Health Nutrition · doi:10.1017/s1368980010001631 · Cited by 19
Effect of Lipid Parameters on Foetal Growth In Gestational Diabetes Mellitus Pregnancies
Simeonova-Krstevska, S., Krstevska, B., Velkoska-Nakova, V., Lega, M. H., Samardjiski, I., Serafimoski, V., Livrinova, V., Todorovska, I., & Sima, A. (2014) · PRILOZI · doi:10.2478/prilozi-2014-0017 · Cited by 19
Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice
Kim, M.-H., de Beer, M. C., Wroblewski, J. M., Charnigo, R. J., Ji, A., Webb, N. R., de Beer, F. C., & van der Westhuyzen, D. R. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m062174 · Cited by 19
Self-citationZheng, Y., Jin, M., Suo, G., Wu, Y., Sun, Y., & Ni, H. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.562853 · Cited by 19
Gan, M., Chen, B., Qin, M., Zhang, L., & Wang, X. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02941-z · Cited by 18
Won, T. W. (2013) · Korean Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.14701/kjhbps.2013.17.3.89 · Cited by 18
Guirgis, F. W., Leeuwenburgh, C., Moldawer, L. L., Ghita, G. L., Black, L. P., Henson, M., DeVos, E., Holden, D. C., Efron, P. A., Reddy, S. T., et al. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00865-x · Cited by 18
Muñoz, M., Fernández‐Barroso, M. Á., López-García, A., Caraballo, C., Núñez, Y., Óvilo, C., González, E., & García-Casco, J. M. (2021) · animal · doi:10.1016/j.animal.2021.100408 · Cited by 18
Lee, Y., Koo, M., Noh, E., Hwang, S. Y., Kim, J. A., Roh, E., Hong, S., Choi, K. M., Baik, S. H., Cho, G. J., et al. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0225 · Cited by 18
Hashim, M., Mohammed, O., Egzeabeher, T. G., & Wolde, M. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09430 · Cited by 18
Lee, Y., Kim, M. Y., Han, K., Kim, B., Park, J., Kim, G., Hur, K. Y., Kim, J. H., & Jin, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-24153-1 · Cited by 18
Self-citationBang, B., Miki, H., & Kang, Y. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1243548 · Cited by 22
Helicobacter pylori (H. pylori) Infection-Associated Dyslipidemia in the Asir Region of Saudi Arabia
Izhari, M. A., Mutawa, O. A. A., Mahzari, A., Alotaibi, E. A., Almashary, M. A., Alshahrani, J. A., Gosady, A. R. A., Almutairi, A. M., Dardari, D. M. M., & AlGarni, A. K. A. (2023) · Life · doi:10.3390/life13112206 · Cited by 19
Roth, A. B., Boess, F., Landes, C., Steiner, G., Freichel, C., Plancher, J., Raab, S., Mudry, C. D. V., Weiser, T. W., & Suter‐Dick, L. (2010) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20375 · Cited by 18
Olorunnisola, O. S., & Afolayan, A. J. (2013) · PubMed · Cited by 18
Lck Inhibits Heat Shock Protein 65–Mediated Reverse Cholesterol Transport in T Cells
Luo, T., Hu, J., Xi, D., Xiong, H., He, W., Liu, J., Li, M., Lü, H., Zhao, J., Lai, W., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502710 · Cited by 18
Lipidomic analysis of immune activation in equine leptospirosis and Leptospira-vaccinated horses
Wood, P. L., Steinman, M., Erol, E., Carter, C. N., Christmann, U., & Verma, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193424 · Cited by 18
Gan, L., He, Y., Liu, L., Ou, Q., & Lin, J. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.08.028 · Cited by 18
Rodríguez‐Carrio, J., Lindholt, J. S., Canyelles, M., Martínez-López, D., Tondo, M., Blanco‐Colio, L. M., Michel, J., Escolá‐Gil, J. C., Suárez, A., & Martı́n-Ventura, J. L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010067 · Cited by 18
Crustacean Hemolymph Lipoproteins
Hoeger, U., & Schenk, S. (2020) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-41769-7_2 · Cited by 18
The influence of exposure to Toxoplasma Gondii on host lipid metabolism
Xu, F., Lu, X., Cheng, R., Zhu, Y., Miao, S., Huang, Q., Xu, Y., Qiu, L., & Zhou, Y. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05138-9 · Cited by 18
“Fuel for the Damage Induced”: Untargeted Metabolomics in Elite Rugby Union Match Play
Hudson, J., Phelan, M., Owens, D. J., Morton, J., Close, G., & Stewart, C. (2021) · Metabolites · doi:10.3390/metabo11080544 · Cited by 18
Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome
González, F., Considine, R. V., Abdelhadi, O. A., Xue, J., & Acton, A. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00213.2021 · Cited by 24
Association of Apolipoproteins with Symptoms of Asthma and Atopy among Schoolchildren
Nagel, G., Weiland, S. K., Rapp, K., Link, B., Zoellner, I., & Köenig, W. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000199722 · Cited by 18
Sundvold, H., Ruyter, B., Østbye, T.-K. K., & Moen, T. (2009) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2009.11.023 · Cited by 18
Bartolomé, N., Aspichueta, P., Martínez, M. J., Vázquez–Chantada, M., Martínez‐Chantar, M. L., Ochoa, B., & Chico, Y. (2010) · Innate Immunity · doi:10.1177/1753425910390722 · Cited by 18
de Oliveira, J. M., Rondó, P. H. D. C., Yudkin, J. S., de Souza, J. M. P., Pereira, T. N., Catalani, A. W., Picone, C. D. M., & Segurado, A. A. C. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462413513748 · Cited by 18
Neves, R. H., Alencar, A. C. M. D. B., Águila, M. B., Mandarim‐de‐Lacerda, C. A., Machado-Silva, J. R., & Gomes, D. C. (2007) · Journal of Helminthology · doi:10.1017/s0022149x07799121 · Cited by 18
Atherogenic Lipid Profile in Behçet’s Disease: Evidence of Alteration of HDL Subclasses
Messedi, M., Jamoussi, K., Frigui, M., Laporte, F., Turki, M., Chaabouni, K., Mnif, E., Jallouli, M., Kaddour, N., Bahloul, Z., et al. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.05.001 · Cited by 18
Nagel, G., Concin, H., Bjørge, T., Rapp, K., Manjer, J., Hallmans, G., Diem, G., Häggström, C., Engeland, A., Almquist, M., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq597 · Cited by 18
Identification of Host Proteins Predictive of Early Stage Mycobacterium tuberculosis Infection
Bark, C. M., Manceur, A. M., Malone, L. L., Nsereko, M., Okware, B., Mayanja‐Kizza, H., Joloba, M. L., Rajotte, I., Mentinova, M., Kay, P., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.06.019 · Cited by 19
He, P., Fan, S., Guan, J., Song, W., Obore, N., Chen, W., Zhi, H., & Wang, L. (2020) · Coronary Artery Disease · doi:10.1097/mca.0000000000000911 · Cited by 18
Lyons, M. A., & Wittenburg, H. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.08.014 · Cited by 18
Sankatsing, R. R., Wit, F. W. N. M., Pakker, N. G., Vyankandondera, J., Mmiro, F. A., Okong, P., Kastelein, J. J. P., Lange, J. M. A., Stroes, E. S. G., & Reiss, P. (2007) · The Journal of Infectious Diseases · doi:10.1086/518248 · Cited by 18
Psychosocial Factors and Coronary Heart Disease: The Role of Psychoneuroimmunological Processes
Steptoe, A., & Brydon, L. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50052-6 · Cited by 18
The lipid paradox in neuroprogressive disorders: Causes and consequences
Morris, G., Berk, M., Walder, K., O’Neil, A., Maes, M., & Puri, B. K. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.017 · Cited by 17
Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis
Birner, C., Mester, P., Liebisch, G., Höring, M., Schmid, S. A., Müller, M., Pavel, V., & Buechler, C. (2024) · Infectious Disease Reports · doi:10.3390/idr16050062 · Cited by 17
Role of HDL in cholesteryl ester metabolism of lipopolysaccharide-activated P388D1 macrophages
Uda, S., Spolitu, S., Angius, F., Collu, M., Accossu, S., Banni, S., Murru, E., Sanna, F., & Batetta, B. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m042663 · Cited by 17
Chavira-Suárez, E., Rosel-Pech, C., Polo‐Oteyza, E., Ancira‐Moreno, M., Ibarra‐González, I., Vela-Amieva, M. B., Meraz‐Cruz, N., Aguilar-Salinas, C. A., & Vadillo‐Ortega, F. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237917 · Cited by 17
Adda-Rezig, H., Carron, C., de Barros, J.-P. P., Choubley, H., Charron, É., Rérole, A.-L., Laheurte, C., Louvat, P., Gaiffe, É., Simula‐Faivre, D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658404 · Cited by 20
Castellanos-García, L. J., Sikora, K. N., Doungchawee, J., & Vachet, R. W. (2021) · The Analyst · doi:10.1039/d1an01783g · Cited by 16
Gong, T., Di, H., Han, X., Hu, X., Liu, C., & Chen, G. (2022) · Endocrine · doi:10.1007/s12020-022-03009-8 · Cited by 17
Behling‐Kelly, E. L., Haak, C. E., Carney, P. C., Waffle, J., Eaton, K., & Goggs, R. A. N. (2022) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16420 · Cited by 17
Robinson, G., Pineda‐Torra, I., Ciurtin, C., & Jury, E. C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.914016 · Cited by 19
Chen, J., Liu, Y., Luo, H., Chen, G., Zheng, Z., Wang, T., Hu, X., Zhao, Y., Tang, J., Su, C., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15070813 · Cited by 17
Toxoplasma gondii infection induces lipid metabolism alterations in the murine host
Milovanovich, I. D., Vujanić, M., Klun, I., Bobić, B., Nikolić, A., Ivović, V., Trbovich, A. M., & Djurković–Djaković, O. (2009) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762009000200008 · Cited by 17
Lin, S., Huang, J. P., Wu, L. Z., Wu, T., & Cui, L. (2013) · PubMed · doi:10.3967/0895-3988.2013.04.003 · Cited by 17
Lee, J. S., Chapman, M. J., Piraino, P., Lamerz, J., Schindler, T. H., Cutler, P., & Dernick, G. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500036 · Cited by 18
Association of a polymorphism of BTN2A1 with dyslipidemia in East Asian populations
Fujimaki, T., Kato, K., Oguri, M., YOHIDA, T., Horibe, H., Yokoi, K., Watanabe, S., Satoh, K., Aoyagi, Y., TANAKA, M., et al. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.266 · Cited by 17
Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow‐up study
Morelli, V. M., Lijfering, W. M., Rosendaal, F. R., & Cannegieter, S. C. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13640 · Cited by 17
Ahn, S. S., Lee, L. E., Pyo, J. Y., Song, J. J., Park, Y., & Lee, S. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01360-1 · Cited by 17
Blood glucose regulation in context of infection
Wensveen, F. M., Šestan, M., Wensveen, T. T., & Polić, B. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2021.06.009 · Cited by 20
Han, Y. M., Lee, J., Choi, J. M., Kwak, M., Yang, J. I., Chung, S. J., Yim, J. Y., & Chung, G. E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260994 · Cited by 17
Park, Y., Cho, C., Emery, P., & Kim, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068975 · Cited by 17
Engström, G., Hedblad, B., Janzon, L., & Lindgärde, F. (2006) · Annals of Epidemiology · doi:10.1016/j.annepidem.2006.03.005 · Cited by 17
Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver
Aspichueta, P., Pérez-Agote, B., Pérez, S., Ochoa, B., & Fresnedo, O. (2006) · Journal of Endotoxin Research · doi:10.1177/09680519060120030501 · Cited by 17
Guerre-Millo, M. (2006) · Journal de la Société de Biologie · doi:10.1051/jbio:2006005 · Cited by 16
Association of a polymorphism of BTN2A1 with dyslipidemia in community-dwelling individuals
Horibe, H., Ueyama, C., Fujimaki, T., Oguri, M., Kato, K., Ichihara, S., & Yamada, Y. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.1902 · Cited by 16
McEneny, J., Henry, S.-L., Woodside, J. V., Moir, S. E., Rudd, A. E., Vaughan, N., & Thiès, F. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.954593 · Cited by 16
Saleh, N. Y., Aboelghar, H. M., Garib, M. I., Rizk, M. S., & Mahmoud, A. A. S. (2023) · Pediatric Research · doi:10.1038/s41390-023-02499-0 · Cited by 16
Chen, Z.-T., Gao, J., Gao, Q., Gao, Q., Zhang, Y., He, W., Wu, M.-X., 刘品明, Wang, J.-F., Zhang, H., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.05.044 · Cited by 16
Jindal, J., Hill, J. W., Harte, J., Dunachie, S. J., & Kronsteiner, B. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156035 · Cited by 16
Khukhodziinai, J. S., Das, P. K., Mukherjee, J., Banerjee, D. K., Ghosh, P. R., Das, A. K., Samanta, I., Jas, R., Mondal, S., & Patra, A. K. (2024) · Animals · doi:10.3390/ani14203008 · Cited by 16
Willers, J., & Hahn, A. (2011) · Rheumatology International · doi:10.1007/s00296-011-2238-7 · Cited by 16
Plasma lipid levels in patients with acute bacterial infections
Nassaji, M., & Ghorbani, R. (2012) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1011-1278 · Cited by 16
Understanding Physiology in the Continuum: Integration of Information from Multiple -Omics Levels
Kamisoglu, K., Acevedo, A., Almon, R. R., Coyle, S. M., Corbett, S., DuBois, D. C., Nguyen, T. T., Jusko, W. J., & Androulakis, I. P. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00091 · Cited by 17
Dacheux, M. A., Sinou, V., Payré, C., Jeammet, L., Parzy, D., Grellier, P., Deregnaucourt, C., & Lambeau, G. J. (2019) · Infection and Immunity · doi:10.1128/iai.00556-19 · Cited by 16
Bu, Y., Wang, H., Ma, X., Han, C. H., Jia, X., Zhang, J., Liu, Y., Peng, Y., Yang, M., Yu, K., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.594270 · Cited by 16
Wu, Y., Xu, Y., Chen, J., Zhao, M., & Rye, K. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-1592-5_3 · Cited by 17
Romero, F. G., Martínez-Calatrava, M. J., Sánchez‐Pernaute, O., Gualillo, O., Largo, R., & Herrero‐Beaumont, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00957.x · Cited by 16
Apolipoprotein A-V is not a major determinant of triglyceride levels during human sepsis
Ngaosuwan, K., Houngngam, N., Limpisook, P., Plengpanich, W., & Khovidhunkit, W. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.03.026 · Cited by 16
Self-citationInvolvement of lipid droplets in hepatic responses to lipopolysaccharide treatment in mice
Arisqueta, L., Núñez-García, M., Ogando, J., García‐Arcos, I., Ochoa, B., Aspichueta, P., Fresnedo, O., & Rueda, Y. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.04.015 · Cited by 16
Zhang, Y., Li, S., Xu, R., Zhu, C., Guo, Y., Wu, N., Sun, J., & Li, J. (2015) · Mediators of Inflammation · doi:10.1155/2015/235742 · Cited by 16
Role of high-sensitivity C-reactive protein measurements in HIV patients
Khan, R., Vishwanath, A., & Quaiser, S. (2016) · Indian Journal of Sexually Transmitted Diseases and AIDS · doi:10.4103/0253-7184.192127 · Cited by 16
ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice
Xiao, H., Wang, J., & Sun, Z. (2017) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2017.11.003 · Cited by 16
Label-free quantitative proteomics of rat hypothalamus under fever induced by LPS and PGE2
Firmino, M., Weis, S. N., de Souza, J. M. F., Gomes, B. R. B., Mól, A. R., Mortari, M. R., de Souza, G. E. P., Coca, G. C., Williams, T. C. R., Fontes, W., et al. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.07.018 · Cited by 16
Evaluation of a type 1 diabetes serum cohort by SELDI‐TOF MS protein profiling
Albrethsen, J., Kaas, A., Schönle, E., Swift, P. G. F., Kočova, M., Gammeltoft, S., Hansen, L., & Mortensen, H. B. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800063 · Cited by 16
Fukuda, T. G., Silva, I. T. F., dos Santos, T. S. S., Filho, M. B. P., de Abreu, F. F., & Filho, J. O. (2022) · BMC Neurology · doi:10.1186/s12883-022-02621-5 · Cited by 15
Trabjerg, M. S., Andersen, D. C., Huntjens, P., Mørk, K., Warming, N., Kullab, U. B., Skjønnemand, M.-L. N., Oklinski, M. K., Oklinski, K. E., Bolther, L., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00450-y · Cited by 15
Jørgensen, S. F., Macpherson, M. E., Skarpengland, T., Berge, R. K., Fevang, B., Halvorsen, B. L., & Aukrust, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199727 · Cited by 17
A pathological convergence theory for non‐communicable diseases
Padrón‐Monedero, A. (2023) · Aging Medicine · doi:10.1002/agm2.12273 · Cited by 17
Cho, K., Bahuguna, A., Kang, D.-J., & Kim, J.-E. (2024) · Antioxidants · doi:10.3390/antiox13010123 · Cited by 14
Sontag, T. J., Carnemolla, R., Vaisar, T., Reardon, C. A., & Getz, G. S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m021154 · Cited by 15
Metadata
- Authors
- Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C.
- Affiliations
- Chulalongkorn University (TH)
- San Francisco VA Medical Center (US)
- Corresponding author
- Feingold, Kenneth R.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2004-07
- Volume
- 45
- Issue
- 7
- Pages
- 1169-1196
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2340325420
- Cited by
- 1,481
- References
- 388
- Citations by year
- 2026: 61 · 2025: 66 · 2024: 68 · 2023: 79 · 2022: 88 · 2021: 90 · 2020: 72 · 2019: 76 · 2018: 73 · 2017: 76 · 2016: 55 · 2015: 54 · 2014: 74 · 2013: 74 · 2012: 72
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK66999, R01DK066999, DK-49900)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- atherogenesis, acute phase response, infection, inflammation, lipid metabolism, lipoprotein metabolism, triglycerides, VLDL secretion, hepatic fatty acid synthesis, lipoprotein lipase, apolipoprotein E, hypercholesterolemia, hepatic cholesterol synthesis, LDL clearance, HDL metabolism, reverse cholesterol transport, LDL oxidation, ceramide, sphingomyelin, macrophage uptake, nuclear receptors, peroxisome proliferator-activated receptors, liver X receptor, farnesoid X receptor, retinoid X receptor, proatherogenic lipoproteins
- MeSH terms
- Animals, Humans, Immunity, Innate, Infections, Inflammation, Lipids, Lipoproteins, Receptors, Cytoplasmic and Nuclear, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review